Predicted Biological Activity of Purchasable Chemical Space
暂无分享,去创建一个
Michael J. Keiser | Teague Sterling | Michael M. Mysinger | John J. Irwin | Garrett Gaskins | J. Irwin | Garrett Gaskins | T. Sterling
[1] Leslie Wilson,et al. Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype , 2015, Cancer Chemotherapy and Pharmacology.
[2] Yukiko Muraki,et al. Comparative functional selectivity of imidafenacin and propiverine, antimuscarinic agents, for the urinary bladder over colon in conscious rats , 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.
[3] Kenneth M Merz,et al. The Ecstasy and Agony of Assay Interference Compounds. , 2017, ACS medicinal chemistry letters.
[4] Armin Ruf,et al. Comparative Molecular Profiling of the PPARα/γ Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors , 2012, ChemMedChem.
[5] Lirong Wang,et al. TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database , 2013, The AAPS Journal.
[6] Christian Buning,et al. Small Macrocycles As Highly Active Integrin α2β1 Antagonists. , 2014, ACS medicinal chemistry letters.
[7] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[8] Grzegorz Godlewski,et al. Atypical cardiostimulant β‐adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues , 2003, British journal of pharmacology.
[9] H. Nishino,et al. Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker. , 1989, Japanese journal of pharmacology.
[10] B Salafsky,et al. Structure-affinity relationships between several new benzodiazepine derivatives and 3H-diazepam receptor sites. , 1984, Japanese journal of pharmacology.
[11] J. Mozrzymas,et al. Comparison of kinetic and pharmacological profiles of recombinant α1γ2L and α1β2γ2L GABAA receptors - A clue to the role of intersubunit interactions. , 2016, European journal of pharmacology.
[12] Scott P. Brown,et al. A unified, probabilistic framework for structure- and ligand-based virtual screening. , 2011, Journal of medicinal chemistry.
[13] Hikaru Tanaka,et al. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels. , 2006, Cardiovascular drug reviews.
[14] Michael Paul Deninno. Discovery of Triazolopyrimidine-Based PDE8B Inhibitors: Exceptionally Ligand-Efficient and Lipophilic Ligand-Efficient Compounds for the Treatment of Diabetes. , 2013 .
[15] P. Hawkins,et al. Comparison of shape-matching and docking as virtual screening tools. , 2007, Journal of medicinal chemistry.
[16] D J Greenblatt,et al. Pharmacology of benzodiazepine hypnotics. , 1992, The Journal of clinical psychiatry.
[17] H. DeLuca,et al. Isolation and identification of 25-hydroxycholecalciferol from human plasma. , 1972, Archives of internal medicine.
[18] S. Mathews,et al. Ciprokiren (Ro 44-9375). A renin inhibitor with increasing effects on chronic treatment. , 1994, Hypertension.
[19] G. R. Brown,et al. Dual-acting thromboxane receptor antagonist/synthase inhibitors: synthesis and biological properties of [2-substituted-4-(3-pyridyl)-1,3-dioxan-5-yl] alkenoic acids. , 1995, Journal of medicinal chemistry.
[20] Tao Huang,et al. MOST: most-similar ligand based approach to target prediction , 2017, BMC Bioinformatics.
[21] Artem Cherkasov,et al. Optimization and structure-activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents. , 2012, Bioorganic & medicinal chemistry.
[22] Alexandra Aubry,et al. Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. , 2009, The Journal of antimicrobial chemotherapy.
[23] Yurii S Moroz,et al. Sulfonyl fluorides as alternative to sulfonyl chlorides in parallel synthesis of aliphatic sulfonamides. , 2014, ACS combinatorial science.
[24] Philip A. MacFaul,et al. Achieving improved permeability by hydrogen bond donor modulation in a series of MGAT2 inhibitors , 2013 .
[25] P. Bork,et al. Drug discovery in the age of systems biology: the rise of computational approaches for data integration. , 2012, Current opinion in biotechnology.
[26] Tudor I. Oprea,et al. The Design of Leadlike Combinatorial Libraries. , 1999, Angewandte Chemie.
[27] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[28] Makoto Araie,et al. Bunazosin, a selective alpha1-adrenoceptor antagonist, as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage. , 2006, Cardiovascular drug reviews.
[29] M. Williams,et al. Effect of Fiduxosin, an Antagonist Selective for α1A- and α1D-Adrenoceptors, on Intraurethral and Arterial Pressure Responses in Conscious Dogs , 2002 .
[30] Andreas Bender,et al. In Silico Target Predictions: Defining a Benchmarking Data Set and Comparison of Performance of the Multiclass Naïve Bayes and Parzen-Rosenblatt Window , 2013, J. Chem. Inf. Model..
[31] T. Kameyama,et al. The interaction of eptazocine, a novel analgesic, with opioid receptors. , 1985, Research communications in chemical pathology and pharmacology.
[32] S Seeber,et al. A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[33] G. Schneider,et al. Review : Macromolecular target prediction by self-organizing feature maps , 2016 .
[34] Makoto Aihara,et al. The effects of prostaglandin analogues on intracellular Ca2+ in ciliary arteries of wild-type and prostanoid receptor-deficient mice. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[35] Ricardo Macarron,et al. Chemical libraries: How dark is HTS dark matter? , 2015, Nature chemical biology.
[36] Thierry Langer,et al. High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening , 2007, J. Comput. Aided Mol. Des..
[37] Yixin Chen,et al. Implementation of multiple-instance learning in drug activity prediction , 2012, BMC Bioinformatics.
[38] Minoru Yamamoto,et al. Effects of a new TRH analogue, YM-14673 on the central nervous system , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.
[39] K. Chergui,et al. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. , 1997, The Journal of pharmacology and experimental therapeutics.
[40] B C McGorum,et al. Bronchodilator activity of the selective muscarinic antagonist revatropate in horses with heaves. , 2013, Veterinary journal.
[41] B. Holmes,et al. Meptazinol , 1983, The Lancet.
[42] Anne Mai Wassermann,et al. Dark chemical matter as a promising starting point for drug lead discovery. , 2015, Nature chemical biology.
[43] Wendy Shelly,et al. Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings , 2008, Obstetrical & gynecological survey.
[44] S Tsukagoshi. [Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist]. , 1999, Gan to kagaku ryoho. Cancer & chemotherapy.
[45] Pierre Baldi,et al. One- to Four-Dimensional Kernels for Virtual Screening and the Prediction of Physical, Chemical, and Biological Properties. , 2007 .
[46] G. Rolinson,et al. Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and Dicloxacillin , 1970, British medical journal.
[47] Thierry Langer,et al. Efficient overlay of small organic molecules using 3D pharmacophores , 2007, J. Comput. Aided Mol. Des..
[48] Natasha Bray. Lead identification: Shedding light on dark chemical matter , 2015, Nature Reviews Drug Discovery.
[49] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[50] Haruko Masumiya,et al. Inhibition of T-Type and L-Type Ca2+ Currents by Aranidipine, a Novel Dihydropyridine Ca2+ Antagonist , 2000, Pharmacology.
[51] Leah Rider,et al. Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer , 2014, Molecular Cancer Therapeutics.
[52] M J Gorrill,et al. Pharmacology of estrogens and estrogen-induced effects on nonreproductive organs and systems. , 1986, The Journal of reproductive medicine.
[53] J R Gibson,et al. Dermatopharmacologic investigations of halobetasol propionate in comparison with clobetasol 17-propionate. , 1991, Journal of the American Academy of Dermatology.
[54] Jun Xu,et al. Toward automated biochemotype annotation for large compound libraries , 2006, Molecular Diversity.
[55] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[56] Richard J Whitby,et al. Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2). , 2011, Journal of medicinal chemistry.
[57] Yong-Yeol Ahn,et al. Optimizing drug–target interaction prediction based on random walk on heterogeneous networks , 2015, Journal of Cheminformatics.
[58] R. N. Brogden,et al. Hexoprenaline: A Review of its Pharmacological Properties and Therapeutic Efficacy with Particular Reference to Asthma , 1977, Drugs.
[59] Jérôme Hert,et al. Quantifying Biogenic Bias in Screening Libraries , 2009, Nature chemical biology.
[60] D. Kass,et al. Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors. , 2012, The American journal of cardiology.
[61] Yvonne C. Martin,et al. Application of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping , 2008, J. Chem. Inf. Model..
[62] D. Attwood,et al. Aggregation of antiacetylcholine drugs in aqueous solution: monomer concentrations in non‐micellar drug systems , 1976, The Journal of pharmacy and pharmacology.
[63] Anne Hersey,et al. Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain. , 2010, Bioorganic & medicinal chemistry letters.
[64] Thomas M Frimurer,et al. 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode. , 2005, Journal of medicinal chemistry.
[65] R. Pieters,et al. Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1. , 2013, Journal of medicinal chemistry.
[66] Antti Poso,et al. Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. , 2006, Journal of medicinal chemistry.
[67] Nobuyoshi Sugaya,et al. Training Based on Ligand Efficiency Improves Prediction of Bioactivities of Ligands and Drug Target Proteins in a Machine Learning Approach , 2013, J. Chem. Inf. Model..
[68] Yurii S. Moroz,et al. One-Pot Parallel Synthesis of Alkyl Sulfides, Sulfoxides, and Sulfones. , 2015, ACS combinatorial science.
[69] Eiichi Fuse,et al. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives. , 2008, Bioorganic & medicinal chemistry letters.
[70] Michael J. Keiser,et al. Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs. , 2010, Journal of medicinal chemistry.
[71] A. Orjales,et al. Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist , 2005, Drugs in R&D.
[72] Anne M. V. Brooks,et al. Ocular β-Blockers in Glaucoma Management , 1992 .
[73] Pavel K Mykhailiuk,et al. Copper-Catalyzed O-Difluoromethylation of Functionalized Aliphatic Alcohols: Access to Complex Organic Molecules with an OCF2H Group. , 2016, The Journal of organic chemistry.
[74] Yurii S Moroz,et al. Expanding Synthesizable Space of Disubstituted 1,2,4-Oxadiazoles. , 2016, ACS combinatorial science.
[75] George Papadatos,et al. The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..
[76] Maria F. Sassano,et al. In Silico Molecular Comparisons of C. elegans and Mammalian Pharmacology Identify Distinct Targets That Regulate Feeding , 2013, PLoS biology.
[77] Simon,et al. A Preliminary Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Hypertension and Angina Pectoris , 2012 .
[78] John J. Irwin,et al. ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..
[79] J. Irwin,et al. Docking Screens for Novel Ligands Conferring New Biology. , 2016, Journal of medicinal chemistry.
[80] T. Hofmann,et al. Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF‐κB‐dependent transcription , 1998, FEBS letters.
[81] E Solito,et al. Anti-inflammatory mechanism of alminoprofen: action on the phospholipid metabolism pathway. , 1999, Biochemical pharmacology.
[82] C B Christensen,et al. The opioid receptor binding profiles of ketobemidone and morphine. , 1993, Pharmacology & toxicology.
[83] F. Dilworth,et al. The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activity. , 1997, Endocrinology.
[84] Isidro Cortes-Ciriano,et al. Chemically Aware Model Builder (camb): an R package for property and bioactivity modelling of small molecules , 2015, Journal of Cheminformatics.
[85] R. Glen,et al. Diversity Selection of Compounds Based on ‘Protein Affinity Fingerprints’ Improves Sampling of Bioactive Chemical Space , 2013, Chemical biology & drug design.
[86] J Mørland,et al. Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose. , 1995, British journal of clinical pharmacology.
[87] J. Irwin,et al. Identifying mechanism-of-action targets for drugs and probes , 2012, Proceedings of the National Academy of Sciences.
[88] E M Sorkin,et al. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. , 1988, Drugs.
[89] P. Skolnick,et al. Triple uptake inhibitors: therapeutic potential in depression and beyond , 2007, Expert opinion on investigational drugs.
[90] J W Oliver,et al. The effects of topical ocular application of 0.25% demecarium bromide on serum acetylcholinesterase levels in normal dogs. , 2003, Veterinary ophthalmology.
[91] Jun Inui,et al. β-adrenoceptor blocking and electrophysiological effects of bufetolol in the guinea pig atria , 1977 .
[92] Yurii S Moroz,et al. 2,2,2-Trifluoroethyl Chlorooxoacetate--Universal Reagent for One-Pot Parallel Synthesis of N(1)-Aryl-N(2)-alkyl-Substituted Oxamides. , 2015, ACS combinatorial science.
[93] Valerie J Gillet,et al. New directions in library design and analysis. , 2008, Current opinion in chemical biology.
[94] Christopher W Murray,et al. Fragment-based lead discovery: leads by design. , 2005, Drug discovery today.
[95] G Castañeda-Hernández,et al. Mechanisms underlying the anti‐inflammatory activity and gastric safety of acemetacin , 2007, British journal of pharmacology.
[96] R. Goldberg,et al. Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. , 1988, Drugs.
[97] Yurii S. Moroz,et al. Bis(2,2,2-trifluoroethyl) carbonate as a condensing agent in one-pot parallel synthesis of unsymmetrical aliphatic ureas. , 2014, ACS combinatorial science.
[98] Subhash C Basak. Mathematical descriptors for the prediction of property, bioactivity, and toxicity of chemicals from their structure: a chemical-cum-biochemical approach. , 2013, Current computer-aided drug design.
[99] G Houin,et al. Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man. , 1984, International journal of clinical pharmacology research.
[100] S. Zozulya,et al. Design, synthesis, and characterization of SO2-containing azabicyclo[3.n.1]alkanes: promising building blocks for drug discovery. , 2015, Organic letters.
[101] Yurii S Moroz,et al. A one-pot parallel reductive amination of aldehydes with heteroaromatic amines. , 2014, ACS combinatorial science.
[102] Murali Gopalakrishnan,et al. Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain. , 2009, Biochemical pharmacology.
[103] Peter Svensson,et al. Influence of Polymorphisms in the HTR3A and HTR3B Genes on Experimental Pain and the Effect of the 5-HT3 Antagonist Granisetron , 2016, PloS one.
[104] Prasenjit Mukherjee,et al. Performance of Dark Chemical Matter in High Throughput Screening. , 2016, Journal of medicinal chemistry.
[105] Jean-Christophe Cassel,et al. Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats , 2001, Pharmacology Biochemistry and Behavior.
[106] Sung Gu Kang,et al. Udenafil: efficacy and tolerability in the management of erectile dysfunction , 2013, Therapeutic advances in urology.
[107] Jayme L. Dahlin,et al. The Essential Medicinal Chemistry of Curcumin , 2017, Journal of medicinal chemistry.
[108] Yongdong Zhang,et al. Drug-target interaction prediction: databases, web servers and computational models , 2016, Briefings Bioinform..
[109] Péter Hári,et al. Virtual Affinity Fingerprints for Target Fishing: A New Application of Drug Profile Matching , 2013, J. Chem. Inf. Model..
[110] Bryan L. Roth,et al. Chemical Informatics and Target Identification in a Zebrafish Phenotypic Screen , 2011, Nature chemical biology.
[111] Lewis R. Vidler,et al. Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B , 2015, Journal of medicinal chemistry.
[112] David J. Wild,et al. Fast rule-based bioactivity prediction using associative classification mining , 2012, Journal of Cheminformatics.
[113] Ulrich Klotz,et al. Interaction Potential of Lercanidipine, a New Vasoselective Dihydropyridine Calcium Antagonist , 2002, Arzneimittelforschung.
[114] A Ward,et al. Pentoxifylline , 1987, Drugs.
[115] Pierre Baldi,et al. One- to Four-Dimensional Kernels for Virtual Screening and the Prediction of Physical, Chemical, and Biological Properties , 2007, J. Chem. Inf. Model..
[116] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[117] A. Markham,et al. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. , 1996, Drugs.
[118] J. Irwin,et al. An Aggregation Advisor for Ligand Discovery. , 2015, Journal of medicinal chemistry.
[119] H Imamura,et al. Beta-adrenoceptor blocking and electrophysiological effects of bufetolol in the guinea pig atria. , 1977, European journal of pharmacology.
[120] R P GUSTAVO. [Anti-gonadotropic action of possipione]. , 1958, Quaderni di clinica ostetrica e ginecologica.
[121] Petra Schneider,et al. Scoring of de novo Designed Chemical Entities by Macromolecular Target Prediction , 2017, Molecular informatics.
[122] Michael Williams,et al. Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs. , 2002, The Journal of pharmacology and experimental therapeutics.
[123] Stefan Vasile,et al. Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro. , 2012, Journal of medicinal chemistry.
[124] J. Palacios,et al. Axonal transport of beta-adrenergic receptors. Antero- and retrogradely transported receptors differ in agonist affinity and nucleotide sensitivity. , 1983, Molecular pharmacology.
[125] Adrià Cereto-Massagué,et al. Tools for in silico target fishing. , 2015, Methods.